Citations (21)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (1)
Nicolas Poirier, Caroline Mary, Stephanie Le Bas-Bernardet, Veronique Daguin, Lyssia Belarif, Melanie Chevalier, Jeremy Hervouet, David Minault, Simon Ville, Vianney Charpy, Gilles Blancho & Bernard Vanhove. (2014) Advantages of Papio anubis for preclinical testing of immunotoxicity of candidate therapeutic antagonist antibodies targeting CD28. mAbs 6:3, pages 697-706.
Read now
Read now
Articles from other publishers (20)
Daniel Keri, Matt Walker, Isha Singh, Kyle Nishikawa & Fernando Garces. (2023) Next generation of multispecific antibody engineering. Antibody Therapeutics.
Crossref
Crossref
Delphine Kervella & Gilles Blancho. (2022) New immunosuppressive agents in transplantation. La Presse Médicale 51:4, pages 104142.
Crossref
Crossref
D. Kervella & G. Blancho. (2022) Nouvelles stratégies immunosuppressives en transplantation. Bulletin de l'Académie Nationale de Médecine 206:4, pages 540-550.
Crossref
Crossref
Sabrina Pengam, Justine Durand, Claire Usal, Vanessa Gauttier, Nahzli Dilek, Bernard Martinet, Véronique Daguin, Caroline Mary, Virginie Thepenier, Géraldine Teppaz, Karine Renaudin, Gilles Blancho, Bernard Vanhove & Nicolas Poirier. (2019) SIRPα/CD47 axis controls the maintenance of transplant tolerance sustained by myeloid-derived suppressor cells. American Journal of Transplantation 19:12, pages 3263-3275.
Crossref
Crossref
Bernard Vanhove, Nicolas Poirier, Jean-Paul Soulillou & Gilles Blancho. (2019) Selective Costimulation Blockade With Antagonist Anti-CD28 Therapeutics in Transplantation. Transplantation 103:9, pages 1783-1789.
Crossref
Crossref
Xiaoqiong Wu, Siqi Chen, Limin Lin, Jiayu Liu, Yanlan Wang, Yumei Li, Qing Li & Zhong Wang. (2018) A Single Domain–Based Anti-Her2 Antibody Has Potent Antitumor Activities. Translational Oncology 11:2, pages 366-373.
Crossref
Crossref
George Adigbli & Fadi Issa. (2018) Preserving Treg Function. Transplantation 102:2, pages 179-182.
Crossref
Crossref
Bernard Vanhove, Nicolas Poirier, Fadi Fakhouri, Laetitia Laurent, Bert ’t Hart, Pedro Papotto, Luiz Rizzo, Masaaki Zaitsu, Fadi Issa, Kathryn Wood, Jean-Paul Soulillou & Gilles Blancho. (2017) Antagonist Anti-CD28 Therapeutics for the Treatment of Autoimmune Disorders. Antibodies 6:4, pages 19.
Crossref
Crossref
Leslie S. Kean, Laurence A. Turka & Bruce R. Blazar. (2017) Advances in targeting co-inhibitory and co-stimulatory pathways in transplantation settings: the Yin to the Yang of cancer immunotherapy. Immunological Reviews 276:1, pages 192-212.
Crossref
Crossref
Alain C. Tissot & Ulrich Brinkmann. 2017. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases. Next-Generation Therapies and Technologies for Immune-Mediated Inflammatory Diseases
75
97
.
Nicolas Poirier, Gilles Blancho, Maryvonne Hiance, Caroline Mary, Tim Van Assche, Jos Lempoels, Steven Ramael, Weirong Wang, Virginie Thepenier, Cecile Braudeau, Nina Salabert, Regis Josien, Ian Anderson, Ian Gourley, Jean-Paul Soulillou, Didier Coquoz & Bernard Vanhove. (2016) First-in-Human Study in Healthy Subjects with FR104, a Pegylated Monoclonal Antibody Fragment Antagonist of CD28. The Journal of Immunology 197:12, pages 4593-4602.
Crossref
Crossref
Akiko Furukawa, Steven A. Wisel & Qizhi Tang. (2016) Impact of Immune-Modulatory Drugs on Regulatory T Cell. Transplantation 100:11, pages 2288-2300.
Crossref
Crossref
Florence Herr, Melanie Brunel, Nathalie Roders & Antoine Durrbach. (2016) Co-stimulation Blockade Plus T-Cell Depletion in Transplant Patients: Towards a Steroid- and Calcineurin Inhibitor-Free Future?. Drugs 76:17, pages 1589-1600.
Crossref
Crossref
Nicolas Poirier, Melanie Chevalier, Caroline Mary, Jeremy Hervouet, David Minault, Paul Baker, Simon Ville, Stephanie Le Bas-Bernardet, Nahzli Dilek, Lyssia Belarif, Elisabeth Cassagnau, Linda Scobie, Gilles Blancho & Bernard Vanhove. (2016) Selective CD28 Antagonist Blunts Memory Immune Responses and Promotes Long-Term Control of Skin Inflammation in Nonhuman Primates. The Journal of Immunology 196:1, pages 274-283.
Crossref
Crossref
Michelle Yap, Sophie Brouard, Claire Pecqueur & Nicolas Degauque. (2015) Targeting CD8 T-Cell Metabolism in Transplantation. Frontiers in Immunology 6.
Crossref
Crossref
Thulasi Ramani, Carol S. Auletta, Daniel Weinstock, Barbara Mounho-Zamora, Patricia C. Ryan, Theodora W. Salcedo & Gregory Bannish. (2015) Cytokines. International Journal of Toxicology 34:4, pages 355-365.
Crossref
Crossref
Cameron McDonald-HymanLaurence A. TurkaBruce R. Blazar. (2015) Advances and challenges in immunotherapy for solid organ and hematopoietic stem cell transplantation. Science Translational Medicine 7:280.
Crossref
Crossref
Steven L. Rosinski, Rainer Storb, Roland K. Strong, George E. Sale, Diane M. Stone, Mesfin M. Gewe, Della J. Friend, V. Kraig Abrams, Julie Randolph-Habecker & Scott S. Graves. (2015) Anti-CD28 Antibody-Initiated Cytokine Storm in Canines. Transplantation Direct 1:2, pages 1-11.
Crossref
Crossref
N. Poirier, N. Dilek, C. Mary, S. Ville, F. Coulon, J. Branchereau, X. Tillou, V. Charpy, S. Pengam, V. Nerriere-Daguin, J. Hervouet, D. Minault, S. Le Bas-Bernardet, K. Renaudin, B. Vanhove & G. Blancho. (2015) FR104, an Antagonist Anti-CD28 Monovalent Fab’ Antibody, Prevents Alloimmunization and Allows Calcineurin Inhibitor Minimization in Nonhuman Primate Renal Allograft. American Journal of Transplantation 15:1, pages 88-100.
Crossref
Crossref
Nahzli Dilek, Nicolas Poirier, Philippe Hulin, Flora Coulon, Caroline Mary, Simon Ville, Henri Vie, Béatrice Clémenceau, Gilles Blancho & Bernard Vanhove. (2013) Targeting CD28, CTLA-4 and PD-L1 Costimulation Differentially Controls Immune Synapses and Function of Human Regulatory and Conventional T-Cells. PLoS ONE 8:12, pages e83139.
Crossref
Crossref